BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3953237)

  • 21. Purification and characterization of an insulin-like growth factor II variant from human plasma.
    Hampton B; Burgess WH; Marshak DR; Cullen KJ; Perdue JF
    J Biol Chem; 1989 Nov; 264(32):19155-60. PubMed ID: 2553732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of a somatomedin from plasma of rats bearing growth hormone secreting tumors.
    Chochinov RH; Mariz IK; Daughaday WH
    Endocrinology; 1977 Feb; 100(2):549-56. PubMed ID: 188631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of three molecular forms of insulin-like growth factor II from human Cohn paste IV.
    Straczek J; Heulin MH; Chenut AM; Lasbennes A; Geschier C; Belleville F; Nabet P
    J Chromatogr; 1990 Nov; 532(2):237-48. PubMed ID: 2084122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of [125I]somatomedin A and [125I]somatomedin C radioreceptor assays for somatomedin peptide content in whole and acid-chromatographed plasma.
    Horner JM; Liu F; Hintz RL
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1287-95. PubMed ID: 263658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a single cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins and antibodies.
    Jansen J; van Buul-Offers SC; Hoogerbrugge CM; Van Den Brande JL
    Biochem J; 1990 Mar; 266(2):513-20. PubMed ID: 2156497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins.
    Van Wyk JJ; Svoboda ME; Underwood LE
    J Clin Endocrinol Metab; 1980 Jan; 50(1):206-8. PubMed ID: 7350184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay.
    Chochinov RH; Mariz IK; Hajek AS; Daughaday WH
    J Clin Endocrinol Metab; 1977 May; 44(5):902-8. PubMed ID: 870516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and biologic properties of fibroblast somatomedin.
    Clemmons DR; Shaw DS
    J Biol Chem; 1986 Aug; 261(22):10293-8. PubMed ID: 2426261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of human semen insulin-like growth factor-I/somatomedin-C immunoreactivity and binding protein.
    Baxter RC; Martin JL; Handelsman DJ
    Acta Endocrinol (Copenh); 1984 Jul; 106(3):420-7. PubMed ID: 6377788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demonstration of type I and type II somatomedin receptors on bovine growth plate chondrocytes.
    Trippel SB; Chernausek SD; Van Wyk JJ; Moses AC; Mankin HJ
    J Orthop Res; 1988; 6(6):817-26. PubMed ID: 2971791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain.
    Carlsson-Skwirut C; Jörnvall H; Holmgren A; Andersson C; Bergman T; Lundquist G; Sjögren B; Sara VR
    FEBS Lett; 1986 May; 201(1):46-50. PubMed ID: 3709807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor-binding protein from human plasma. Purification and characterization.
    Martin JL; Baxter RC
    J Biol Chem; 1986 Jul; 261(19):8754-60. PubMed ID: 3722172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple and efficient scheme for the purification of insulin-like growth factor II from human bone matrix extract.
    Mohan S
    Growth Factors; 1990; 2(4):267-71. PubMed ID: 2337472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial purification and characterization of a neutral insulin-like growth factor. Biochemical and biological properties.
    Minuto F; Barreca A; Del Monte P; Giordano G
    Biochem Int; 1986 Aug; 13(2):253-61. PubMed ID: 3768011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II.
    Gowan LK; Hampton B; Hill DJ; Schlueter RJ; Perdue JF
    Endocrinology; 1987 Aug; 121(2):449-58. PubMed ID: 2439316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of leprechaunism with disorders of insulin-like growth factor-I(IGF-I)/somatomedin C(SMC) binding protein and its receptor].
    Funakoshi T; Morikawa H; Yamasaki A; Kobayashi A; Ueda Y; Mochizuki M; Matsuo M; Nakamura H; Matsuo T; Itoh H
    Nihon Naibunpi Gakkai Zasshi; 1989 Feb; 65(2):99-112. PubMed ID: 2472974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor I/somatomedin C (IGF-I/Sm C): comparison of natural, solid phase synthetic and recombinant DNA analog peptides in two radioligand assays.
    Schalch D; Reismann D; Emler C; Humbel R; Li CH; Peters M; Lau E
    Endocrinology; 1984 Dec; 115(6):2490-2. PubMed ID: 6389098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction.
    Daughaday WH; Parker KA; Borowsky S; Trivedi B; Kapadia M
    Endocrinology; 1982 Feb; 110(2):575-81. PubMed ID: 7035142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of a somatomedin-binding protein from preterm amniotic fluid. Development of a radioimmunoassay.
    Drop SL; Kortleve DJ; Guyda HJ
    J Clin Endocrinol Metab; 1984 Nov; 59(5):899-907. PubMed ID: 6207199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The purification and partial characterization of human somatomedin C.
    Liberti JP; Miller MS
    J Biol Chem; 1980 Feb; 255(3):1023-9. PubMed ID: 7356647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.